Nemaura Medical to Present at the Planet MicroCap Showcase 2022 | News

Loughborough, England, April 25, 2022 (Globe NEWSWIRE) — Nemaura Health-related, Inc. (NASDAQ: NMRD), a health-related…

Nemaura Medical to Present at the Planet MicroCap Showcase 2022 | News

Loughborough, England, April 25, 2022 (Globe NEWSWIRE) — Nemaura Health-related, Inc. (NASDAQ: NMRD), a health-related know-how corporation concentrated on developing and commercializing wearable diagnostic units and supporting personalized way of life coaching courses, announces these days that CEO Dr. Faz Chowdhury will current pretty much at the Earth MicroCap Showcase 2022. The conference is staying held on May perhaps 3 – 5, 2022 at The Bally’s Lodge & Casino in Las Vegas, NV.

Dr.Chowdhury will be out there for a single-on-a single meetings. To request a meeting and to sign-up for the convention, simply click here: https://planetmicrocapshowcase.com/signup

About Nemaura Medical, Inc.

Nemaura Clinical, Inc. is a health-related technology business creating and commercializing wearable diagnostic units. The corporation is presently commercializing sugarBEAT® and proBEAT™. sugarBEAT®, a CE mark authorised Class IIb healthcare machine, is a non-invasive and versatile continual glucose monitor (CGM) supplying actionable insights derived from actual time glucose measurements and daily glucose development information, which may assist persons with diabetic issues and pre-diabetic issues to superior deal with, reverse, and avert the onset of diabetes. Nemaura has submitted a PMA (Premarket Acceptance Software) for sugarBEAT® to the U.S. Fda. proBEAT™ combines non-invasive glucose info processed making use of artificial intelligence and a digital healthcare subscription assistance and has been introduced in the U.S. as a general wellness product or service as section of its BEAT®diabetes application that is presently undergoing pilot research.

Moreover, Nemaura has introduced Miboko, a new metabolic overall health and perfectly-becoming program utilizing a non-invasive glucose sensor together with an AI cell application that allows a consumer recognize how specific foods and way of living routines can affect one’s general metabolic wellness and nicely-being. Nemaura believes that up to 50 percent the inhabitants could profit from a sensor and software that screens metabolic wellness and effectively-staying.

The Enterprise sits at the intersection of the world wide Type 2 diabetic issues industry that is anticipated to access nearly $59 billion by 2025, the $50+ billion pre-diabetic marketplace, and the wearable well being-tech sector for bodyweight reduction and wellness applications that is estimated to arrive at $60 billion by 2023.

For additional information and facts, you should take a look at www.NemauraMedical.com.

Make contact with:

Jules Abraham Main IR 917-885-7378 [email protected]

Copyright 2022 GlobeNewswire, Inc.